Skip to main content

Day: January 15, 2025

HP Announces 2025 Digital Equity Accelerator to Drive Global Digital Inclusion

Accelerator will support nonprofits in Greece, Indonesia, Nigeria, and Spain to bridge the digital divide News HighlightsApplications are now open for The Digital Equity Accelerator. Qualified organizations in Greece, Indonesia, Nigeria, and Spain are invited to apply until February 12, 2025. The Digital Equity Accelerator, a joint initiative between HP Inc. and the HP Foundation, helps nonprofit organizations scale innovative approaches to meet digital inclusion needs among youth and adults who are historically disconnected. In its first three years, the Accelerator helped 27 participating organizations expand their reach by more than 9 million.PALO ALTO, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) —  To bridge the global digital divide and build the future of work, HP Inc. (NYSE: HPQ) and the HP Foundation are launching the 2025...

Continue reading

New Toll Brothers Model Homes Open in Parkside Village Community in Aldie, Virginia

Exclusive community offers single-family homes with access to a robust selection of amenities in sought-after Loudoun County ALDIE, Va., Jan. 15, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE: TOL), the nation’s leading builder of luxury homes, announced the grand opening of its model homes at Parkside Village, offering single-family homes on expansive home sites in an exclusive, intimate setting in Aldie, Virginia. The Wistman and Konni model homes, located at 41545 Dogwood Park Circle in Aldie, feature innovative architecture and the perfect blend of luxury and modern design. “The newly opened model homes showcase the exceptional luxury designs that Toll Brothers offers at Parkside Village and serve as an inspiration for the finish selections that our home buyers will experience firsthand at Toll Brothers Design Studio and...

Continue reading

JBTC Announces 4th Quarter 2024 Earnings

JONESTOWN, Pa., Jan. 15, 2025 (GLOBE NEWSWIRE) — JBT Bancorp, Inc. (OTCQX: JBTC) reported quarterly earnings of $1,775,000 with earnings per share of $0.73. Earnings were down 14.38% compared to the final quarter of 2023 as there was a corresponding $482,000 increase in credit loss expense. Full-year unaudited earnings were $7,555,000 with earnings per share of $3.10. Earnings fell 3.05% from $7,793,000 and earnings per share were down from $3.20 in the prior year.    President & CEO, Troy A. Peters, commented, “We are proud of our growth this past year, particular in attracting core deposits and surpassing the $950 million asset mark. Growth, in the short-term, requires provisioning expense which increased by 44.81% over the prior year. Our margin performance was also strong against the rate cuts in the fourth quarter.” More...

Continue reading

Digital Utilities Ventures, Inc. Announces Strategic Partnership with TradersQue LLC to Support Growth and Expansion Initiatives

MANKATO, Minn., Jan. 15, 2025 (GLOBE NEWSWIRE) — Digital Utilities Ventures (OTC: DUTV), a green solutions company focused on regenerative agriculture and clean water technologies, is pleased to announce a strategic partnership with TradersQue LLC (www.TradersQue.com). The collaboration aims to leverage TradersQue’s innovative business solutions to support DUTV’s ongoing growth and expansion efforts across the Agricultural and other new markets. This partnership will provide DUTV with essential tools and resources to enhance operational efficiency, drive sales initiatives, and optimize market strategies. By tapping into TradersQue’s SaaS solutions and affiliate network, DUTV is positioned to further its mission of delivering sustainable and innovative technologies to global markets. CEO Mark Gaalswyk commented, “We are excited...

Continue reading

Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare’s Landmark Report

VANCOUVER, British Columbia, Jan. 15, 2025 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is excited to announce that its cutting-edge anti-aging compound, TFC-1326, has been highlighted in Stonegate Healthcare Partners’ latest research report. The publication, titled “Sirona Biochem’s TFC-1326 Clinical Data Versus Retinoid Clinical Data,” provides an extensive evaluation of TFC-1326’s clinical trial performance, setting it apart from traditional retinoid treatments. The report outlines the remarkable benefits of TFC-1326, including:Boosting skin radiance Significantly reducing wrinkle depth and volume Enhancing skin elasticity and firmness Ensuring deep hydration with no irritationStonegate Healthcare’s analysis underscores TFC-1326’s ability to deliver rapid, consistent results while...

Continue reading

Ipsos successfully completes a bond issuance of €400 million

Ipsos successfully completes a bond issuance of €400 million Paris, 15 January 2025 – Ipsos, one of the world’s leading market research companies, announces the successful issuance of its first rated bond for €400 million. The bond is maturing in January 2030 and carrying a coupon of 3.75%. Ipsos is rated Baa3 with stable outlook by Moody’s and BBB with stable outlook by Fitch. The very strong investor demand, with an orderbook covering more than 9 times the size of the bond, is a testament to their confidence in Ipsos’ business model and credit profile. This substantial level of oversubscription allowed Ipsos to price the bond with a final spread significantly below initial price indication. The proceeds will be used for general corporate purposes, including the refinancing of its €300 million existing bond maturing in September 2025. DisclaimerThis...

Continue reading

Mullen Group Ltd. 2024 Year-End and Fourth Quarter Earnings Conference Call and Webcast

OKOTOKS, Alberta, Jan. 15, 2025 (GLOBE NEWSWIRE) — (TSX: MTL) Mullen Group Ltd. (“Mullen Group” and/or the “Corporation“) intends to release its 2024 Year-End and Fourth Quarter earnings results on Thursday, February 13, 2025, at 6:00 a.m. ET, and has scheduled a conference call and webcast as follows:Date: February 13, 2025   Time: 10:00 a.m. ET   Pre-Registration: registration link     Upon registering, you will receive a calendar booking by email with dial in details and a unique PIN. This process will bypass the operator and avoid the queue. Registration will remain open until the end of the conference call.   Dial-in: 1-844-763-8274 (for participants in North America)  +1-647-484-8814 (International participants)   Webcast: www.mullen-group.com   Replay: Two...

Continue reading

InflaRx Receives European Commission Approval for GOHIBIC® (vilobelimab) for the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS)

JENA, Germany, Jan. 15, 2025 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the European Commission (EC) has granted marketing authorization under exceptional circumstances for GOHIBIC® (vilobelimab) for the treatment of adult patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS) who are receiving systemic corticosteroids as part of standard of care and receiving invasive mechanical ventilation (IMV) with or without extracorporeal membrane oxygenation (ECMO). GOHIBIC is the first and only treatment approved in the European Union for the treatment of SARS-CoV-2-induced ARDS. Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx, commented: “The European Commission’s...

Continue reading

Alstom S.A: Alstom to overhaul and modernize 181 Bi-Level commuter rail cars for Metrolinx in Ontario, Canada

                                                                                                    Mid-life overhaul and upgrades of the Bi-Level series VIII cars will begin by 2026 at Alstom’s facility in Thunder Bay and will support approximately 250 high-skilled jobs until at least 2030. The framework agreement is worth approximately 500 million CAD (approximately 340 million EUR). Alstom is a long-term and dedicated partner of Metrolinx providing rolling stock, signalling, maintenance, and rail operation services to Ontario for close to 50 years.15 January 2025 – Alstom, global leader in smart and sustainable mobility, has signed a new agreement with Metrolinx to overhaul and modernize 181 Bi-Level commuter rail cars for GO Transit, the regional public transit service for the Greater Golden Horseshoe in Ontario, Canada. The framework...

Continue reading

Sanofi: Information concerning the total number of voting rights and shares – November 2024

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)    Sanofia French société anonyme with a registered share capital of 2,537,214,304 €Registered office : 46, avenue de la Grande Armée – 75017 Paris – FranceRegistered at the Paris Commercial and Companies Registry under number 395 030 844Date   Total number of issued shares   Number of real voting rights(excluding treasury shares) Theoretical number of voting rights (including treasury shares)*October 31, 2024 1,268,922,721 1,413,173,242 1,428,504,323* Pursuant to article 223-11 of the Règlement général de l’Autorité...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.